Biocorp has gained approval in Europe for the Mallya smart sensor, a device that records key treatment information for diabetic patients.

The sensor connects conventional insulin pens to a mobile app, tracking the selected dose, date and time of injection. The automated recording eliminates the need for logbooks and manual recordkeeping.

The device also creates a summary report of a patient’s injected doses over the previous three months.